Medifies provides real-time surgery notifications for patients' families and caregivers. We improve patient satisfaction, save staff time, and minimize liability and are live with paying customers!
Medifies is now live with paying customers with a secure, HIPAA-compliant SaaS platform than enables healthcare providers to keep families in the loop as medical procedures progress with standardized messaging, giving family unprecedented peace of mind.
This current lack of information is a familiar pain point; all of us have sat in hospital waiting rooms with no idea what is happening. Patients, hospitals, surgeons and families all want to see this problem solved.
Medifies positively affects providers' revenues, too.
We have a subscription-based, SaaS B2B model that will also drive revenue from upsells of our other planned products (radiology, chemotherapy, dialysis, OB, elder care) and fees for setup, analytics, and 24/7 support. The platform is HIPAA-compliant and uses bank-grade security. We do not display any PHI or PII, and the patient invites their family members, protecting those patients' privacy and the hospitals security. Medifies is simple and intuitive to use by both family members and healthcare staff.
Fun fact: The concept is from the Chief of Surgery at Sutter, a co-founder and investor who has known the CEO since 6th grade!
Children's Hospital of New Orleans wants Medifies Pre-op to stem their 31% no show rate. $380k/yr bid accepted.June, 2018
Growing fast! Medifies has hired a new operations manager, 2 new territory sales directors and 2 customer success people in last month.June, 2018
Live with first Tenet hospital. 3 year contract - already paid $78k. Tenet is 84 hospital and 450 surgicenter system, NYSE traded.May, 2018
SaaS software sales expert, Joel Carabello joined the Medifies Board of Advisors and doubles down on investment.March, 2018
Texas Children's Hospital requested a Statement of Work to begin the contracting process for a Medifies Radiology product.February, 2018
First Revenue! $78,000 check for 1 year up front for Doctors Medical Center (large Tenet hospital in Modesto, CA) three-year sales contractFebruary, 2018
Conducted a day of workflow observation at Kelsey-Seybold to strategize Medifies implementation thereOctober, 2017
Completed Texas Medical Center Innovation Institute Accelerator (4th cohort, digital health)June, 2017
Version 1 of the Medifies Surgery platform releasedFebruary, 2017
Finished building MVPOctober, 2016
Total market for all products in the platform is $15B in the US alone.
Operating room communication is only the first step for Medifies. The product roadmap includes tools for communicating throughout the entire perioperative cycle, as well as products for other procedes, like radiology, chemotherapy, and labor and delivery.
The market for a provider-to-caregiver communication is nascent; most tools focus on doctor-to-patient communication. The closest solution to Medifies is EASE, an app that allows nurses to send photos of patients in surgery and type free-text updates which disappear after 60 seconds. Two other solutions are Medicend, which is similar to Medifies but without our traction or patient acquisition ROI, and Mutare Health, which is patient-focused but has a small family add-on option.
Yes. We've heard different opinions from executives; some want us to integrate with an EMR to streamline the process, while some want to avoid EMR integration to go live sooner and keep implementation simple. Our CTO has significant experience with both FHIR and HL7 integration protocols, and we can integrate with an EMR upon request. For example, Texas Children's Hospital is paying for us to integrate with their Epic implementation.
Our experienced team is perhaps our biggest competitive advantage. We are also "mobile-first," and we have an IP plan that includes light AI around "comfort messages" for family members. Our patient acquisition ROI model--which is very important to healthcare providers--is unique, and we enjoy a natural network effect as caregivers sign up.
The head of business development (Carin Sarkis - our champion) for the first Tenet hospital in which we are currently live (with her budget) said to me that the first hospital that InQuicker sold to was in fact her hospital and InQuicker then went from that one hospital to being bought for (made available to by corporate in Dallas) all 89 hospitals in the Tenet network within two years; then within three years it was required for all 89 tenet at hospitals by Tenet corporate. The next year that company, InQuicker, was bought by Stericycle.
This is a startup company. While the CEO has sold several companies before, with acquisition prices totaling $1.4 billion, and a ROI of 122x in one deal in particular, past success is no guarantee of future performance.
Medifies expects you to be an accredited investor as such term is defined in Rule 501 of Regulation D under the Securities Act. Medifies wants you to know that that this financing instrument and the underlying securities have not been registered under the Securities Act, or any state securities laws and, therefore, cannot be resold unless they are registered under the Securities Act and applicable state securities laws or unless an exemption from such registration requirements is available.
You would be purchasing this instrument and the securities to be acquired by you for your own account for investment, not as a nominee or agent, and not with a view to, or for resale in connection with, the distribution thereof, and you should have no present intention of selling, granting any participation in, or otherwise distributing the same. You should have such knowledge and experience in financial and business matters that you are capable of evaluating the merits and risks of such investment, are able to incur a complete loss of such investment without greatly impairing your financial condition, and are able to bear the economic risk of such investment for an indefinite period of time.
The CEO, his co-founder and 3 board of advisor members (and several other accredited investors) have invested under the exact same terms as are offered here.